Search research articles
Contact Us
Filters
Showing results (51-60 of 468) with videos related to
Page
of 47
Sort By:
World Neurosurgery
|
March 17, 2017
Biomarkers and Immunotherapeutic Targets in Glioblastoma
Alice L Hung, Tomas Garzon-Muvdi, Michael Lim
Current Treatment Options in Oncology
|
March 19, 2013
Metastatic melanoma to the brain: surgery and radiation is still the standard of care
Sarah Nicholas, Dimitrios Mathios, Christopher Jackson, et al.
Cancers
|
June 13, 2025
The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities
Ravi Medikonda, Matthew Abikenari, Ethan Schonfeld, et al.
Scandinavian Journal of Pain
|
December 13, 2017
Targeting cytokines for treatment of neuropathic pain
Alice L Hung, Michael Lim, Tina L Doshi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2014
Immunotherapy for brain cancer: recent progress and future promise
Christopher M Jackson, Michael Lim, Charles G Drake
Frontiers in Immunology
|
March 10, 2022
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
Ya-Jui Lin, Leila A Mashouf, Michael Lim
Neurosurgery Clinics of North America
|
July 4, 2012
Clinical trials with immunotherapy for high-grade glioma
Jacob Ruzevick, Christopher Jackson, Jillian Phallen, et al.
Neuro-Oncology
|
March 4, 2025
Molecular-based decision-making in glioblastoma surgery: when to aim for supramaximal resection
Richard Drexler, Michael Lim, Shawn L Hervey-Jumper
Chinese Clinical Oncology
|
September 13, 2022
Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review
Janet Y Wu, Alexander L Ren, Michael Lim
Neuro-Oncology Advances
|
September 11, 2025
Current landscape of immunotherapy for CNS tumors
Alexander P Landry, Gavin P Dunn, Michael Lim
Page
of 47
Search research articles
Search
Showing results (51-60 of 468) with videos related to
Sort By:
Page
of 47
World Neurosurgery
|
March 17, 2017
Biomarkers and Immunotherapeutic Targets in Glioblastoma
Alice L Hung, Tomas Garzon-Muvdi, Michael Lim
Current Treatment Options in Oncology
|
March 19, 2013
Metastatic melanoma to the brain: surgery and radiation is still the standard of care
Sarah Nicholas, Dimitrios Mathios, Christopher Jackson, et al.
Cancers
|
June 13, 2025
The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities
Ravi Medikonda, Matthew Abikenari, Ethan Schonfeld, et al.
Scandinavian Journal of Pain
|
December 13, 2017
Targeting cytokines for treatment of neuropathic pain
Alice L Hung, Michael Lim, Tina L Doshi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2014
Immunotherapy for brain cancer: recent progress and future promise
Christopher M Jackson, Michael Lim, Charles G Drake
Frontiers in Immunology
|
March 10, 2022
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
Ya-Jui Lin, Leila A Mashouf, Michael Lim
Neurosurgery Clinics of North America
|
July 4, 2012
Clinical trials with immunotherapy for high-grade glioma
Jacob Ruzevick, Christopher Jackson, Jillian Phallen, et al.
Neuro-Oncology
|
March 4, 2025
Molecular-based decision-making in glioblastoma surgery: when to aim for supramaximal resection
Richard Drexler, Michael Lim, Shawn L Hervey-Jumper
Chinese Clinical Oncology
|
September 13, 2022
Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review
Janet Y Wu, Alexander L Ren, Michael Lim
Neuro-Oncology Advances
|
September 11, 2025
Current landscape of immunotherapy for CNS tumors
Alexander P Landry, Gavin P Dunn, Michael Lim
Page
of 47